BRPI0813104A2 - Composto - Google Patents

Composto

Info

Publication number
BRPI0813104A2
BRPI0813104A2 BRPI0813104-0A2A BRPI0813104A BRPI0813104A2 BR PI0813104 A2 BRPI0813104 A2 BR PI0813104A2 BR PI0813104 A BRPI0813104 A BR PI0813104A BR PI0813104 A2 BRPI0813104 A2 BR PI0813104A2
Authority
BR
Brazil
Prior art keywords
compound
Prior art date
Application number
BRPI0813104-0A2A
Other languages
English (en)
Inventor
Junichi Mitsuyama
Naokatu Aoki
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of BRPI0813104A2 publication Critical patent/BRPI0813104A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4453Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0813104-0A2A 2007-07-04 2008-07-02 Composto BRPI0813104A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007176106 2007-07-04
PCT/JP2008/061944 WO2009005077A1 (ja) 2007-07-04 2008-07-02 4-{3-[4-(3-{4-[アミノ(ブトキシカルボニルイミノ)メチル]フェノキシ}プロピル)-1-ピペリジニル]プロポキシ}-n’-(ブトキシカルボニル)ベンズアミジンの新規な結晶

Publications (1)

Publication Number Publication Date
BRPI0813104A2 true BRPI0813104A2 (pt) 2014-12-23

Family

ID=40226120

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813104-0A2A BRPI0813104A2 (pt) 2007-07-04 2008-07-02 Composto

Country Status (22)

Country Link
US (1) US8158800B2 (pt)
EP (1) EP2189446B1 (pt)
JP (1) JP5261386B2 (pt)
KR (1) KR20100027176A (pt)
CN (1) CN101730682B (pt)
AU (1) AU2008272124B2 (pt)
BR (1) BRPI0813104A2 (pt)
CA (1) CA2691954C (pt)
CY (1) CY1113210T1 (pt)
DK (1) DK2189446T3 (pt)
ES (1) ES2391319T3 (pt)
HR (1) HRP20120796T1 (pt)
IL (1) IL202804A (pt)
MX (1) MX2009013913A (pt)
NZ (1) NZ582187A (pt)
PL (1) PL2189446T3 (pt)
PT (1) PT2189446E (pt)
RU (1) RU2456272C2 (pt)
SI (1) SI2189446T1 (pt)
TW (1) TWI395735B (pt)
WO (1) WO2009005077A1 (pt)
ZA (1) ZA201000027B (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008526A (es) * 2002-03-06 2005-07-13 Toyama Chemical Co Ltd Novedoso derivado de arilamidina o sal del mismo.
JP4885722B2 (ja) 2004-06-30 2012-02-29 富山化学工業株式会社 新規なアリールアミジン誘導体およびその塩ならびにそれらを含有する抗真菌剤
CN101351204B (zh) * 2005-12-29 2011-01-12 富山化学工业株式会社 芳脒衍生物及其盐、以及含有它们的抗真菌药
SI2070536T1 (sl) * 2006-10-06 2012-03-30 Toyama Chemical Co Ltd Farmacevtska sestava vsebujoča derivat fenilamidina in postopek z uporabo farmacevtske sestave vkombinaciji s protiglivičnim sredstvom

Also Published As

Publication number Publication date
IL202804A0 (en) 2010-06-30
DK2189446T3 (da) 2012-09-24
AU2008272124A1 (en) 2009-01-08
AU2008272124B2 (en) 2012-08-23
CA2691954C (en) 2014-10-28
RU2010103672A (ru) 2011-08-10
EP2189446A4 (en) 2010-10-20
CA2691954A1 (en) 2009-01-08
NZ582187A (en) 2011-03-31
JP5261386B2 (ja) 2013-08-14
MX2009013913A (es) 2010-03-10
JPWO2009005077A1 (ja) 2010-08-26
PL2189446T3 (pl) 2013-01-31
EP2189446B1 (en) 2012-08-22
EP2189446A1 (en) 2010-05-26
SI2189446T1 (sl) 2012-12-31
US20110046381A1 (en) 2011-02-24
TWI395735B (zh) 2013-05-11
HRP20120796T1 (hr) 2012-10-31
RU2456272C2 (ru) 2012-07-20
IL202804A (en) 2013-10-31
CN101730682B (zh) 2012-08-08
CN101730682A (zh) 2010-06-09
TW200914421A (en) 2009-04-01
ES2391319T3 (es) 2012-11-23
ZA201000027B (en) 2011-03-30
KR20100027176A (ko) 2010-03-10
PT2189446E (pt) 2012-10-25
CY1113210T1 (el) 2016-04-13
WO2009005077A1 (ja) 2009-01-08
US8158800B2 (en) 2012-04-17

Similar Documents

Publication Publication Date Title
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
DK2185567T3 (da) Substituerede bicyclolactam-forbindelser
EP2170350A4 (en) SUBSTITUTED IMIDAZOHETEROCYCLES
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
DK2203462T4 (da) Nukleosid-phosphoramidat-prodrugs
EP2164799A4 (en) DOSING DISTRIBUTION CONTAINERS WITH COMBINATION UNIT
BRPI0821573A2 (pt) benzofuropirimidonas
EP2185560A4 (en) HETEROARYLAMIDE ANALOGS
ATE501136T1 (de) Imidazopyridinone
BRPI0811264A2 (pt) Compostos
EP2226481A4 (en) EXHAUST POT
BRPI0809996A2 (pt) Compostos
BRPI0814424A2 (pt) Compostos heterociclila
EP2149500A4 (en) Electron beam sterilizer
DE602008004695D1 (de) Katalysatorträgerwabe
EP2208322A4 (en) GRID ROUTER
BRPI0923592A2 (pt) composto
BRPI0815181A2 (pt) Compostos
EP2058570A4 (en) Marine hose
DE502008001694D1 (de) Mitfahrhubwagen
FI20070655A0 (fi) Imuhihnakuljetin
BRPI0814613A2 (pt) Compostos
LT3825306T (lt) Morfinano junginiai
BRPI0913805A2 (pt) composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.